Session 8: Inherited cardiomyopathies
Co-chairs: Eleanor Wicks and Dimitra Antonakaki
Thursday, 12 October 2023
Quiz / certificate
After viewing the recordings, try to answer the online quiz to generate a session certificate.
You must correctly answer 5 of 6 quiz questions (83%) to pass.
You may take the quiz as many times as you wish.
You can review the correct answers by clicking the “View score” button after submission.
At busy times, it may take up to 72 hours to receive your certificate. If you do not see it, please check your junk mail folder.
CLICC 2023 (part 2) Inherited cardiomyopathies
Session 8: Co-chairs - Eleanor Wicks and Dimitra Antonakaki| Link | Topic / presenter |
|---|---|
| View recording | Chair welcome and introductions |
| View recording | New therapies for hypertrophic cardiomyopathy Dr Brian Halliday Royal Brompton and Harefield Hospitals |
| View recording | Clinical scientist led services (ICC screening and LVOTO clinics) Ms Jane Draper Guy’s and St Thomas’ hospitals |
| View recording | Gene-targeted therapy trials relevant to ICC Dr Paz Tayal Royal Brompton and Harefield Hospitals |
| View recording | Amyloidosis: Diagnostic journey, genetic testing and novel treatments Prof Marianna Fontana National Amyloidosis Centre |
| View recording | Panel discussion (led by co-chairs) |
| View recording | LVNC: Time for declassification? Dr Andrew D’Silva Guy’s and St Thomas’ hospitals |
| View recording | Acute myocarditis and inherited cardiomyopathy Dr Amrit Lota Royal Brompton and Harefield hospitals |
| View recording | Clinical screening for first degree relatives: Time to personalise the approach? Ms Bethan Cowley Royal Brompton and Harefield hospitals |
| View recording | Cardiomyopathy UK survey 2023 Mr Joel Rose Cardiomyopathy UK |
| View recording | MDT cases (x2) Dr Stefi Rosmini, King's College Hospital Dr Lynne Millar, Guy’s and St Thomas’ hospitals |
| View recording | Panel discussion (Led by co-chairs) |
Co-chairs
Dimitra Antonakaki
Dimitra graduated with honours from the Medical University of Athens in Greece. She completed her Medical and Cardiology training and obtained her CCT in London. She subsequently subspecialised in Inherited Cardiac Conditions and multimodality Cardiovascular Imaging at Barts Heart Centre, London. During this time, she obtained a competitive scholarship from St George’s University of London to study the Sports Cardiology MSc and graduated with distinction.
More recently, Dimitra has sat on the National Association of Inherited Cardiac Conditions (AICC) Council as the trainee representative. She also helped co-create the AICC’s official website. She has been a Consultant Cardiologist in Inherited Cardiac Conditions at the John Radcliffe University Hospital in Oxford and Royal County Sussex University CTC. In addition, Dimitra is an Honorary Senior Clinical Lecturer at St George’s University of London where she is the Lead of the Advanced Management and Genomics of Inherited Cardiac Conditions MSc module.
Dimitra has specialist interests in ICC genomics, cardiac MRI, and sports cardiology and is an active member of the Media Task Force of the ESC Council on Cardiovascular Genomics and the EAPC Sports Cardiology and Exercise section.
Eleanor Wicks
Eleanor leads the Oxford ICC service. She has longstanding specialist interests in inherited and acquired (including inflammatory) conditions, genomics, heart failure and multimodality imaging. She studied Medicine at the University of Edinburgh. After qualifying in 2004, she trained in General Medicine, gaining membership of the Royal College of Physicians in 2009 and completed her general cardiology training at Barts Heart Centre, London. She was appointed as a Consultant Cardiologist with dual accreditation in General Medicine in 2016 and moved to Oxford in 2017.
Eleanor harnesses clinical and academic synergy via collaborative networks to help define disease mechanisms and ensure the translation of novel molecular biological and clinical research approaches into clinical practice. She utilises state-of-the-art genomics and imaging for rich phenotyping to help reveal the molecular, imaging and genetic basis of inherited and acquired heart diseases in search of improved diagnoses, risk stratification and the exploration of potential therapeutic targets in the hope of delivering personalised therapy with substantial benefits for patients.